Dr. Rupinder Kaur Sodhi from Chandigarh College of Pharmacy (CCP), CGC Landran and Dr. Bodhisatwa Das from IIT Ropar have been awarded a grant of 71 Lakh Rupees by the Department of Biotechnology, Government of India for a joint project to develop a
The study said a plethora of anti-parasitic and anti-viral drugs, monoclonal antibodies, vaccines and stem cell therapies were tried as part of well-designed clinical trials.
HYDERABAD: Covid-19 is emerging as perhaps the first pandemic in human history for the treatment of which over 200 drug compounds have been tested and about 70 therapeutic agents subjected to clinical trials so far.
A research study involving scientists, including those from the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, found that as many as 265 clinical trials were conducted to find a suitable treatment for the virus and of them, 115 have been shown to have direct effect on reducing the viral load and managing the disease.